Deemed as the “drug that changed the breast cancer treatment landscape,” Herceptin has saved millions of women's lives ...

Do not stop your Herceptin SC treatment without talking to your doctor first. Do not take any other medicines, whether they require a prescription or not, without first telling your doctor or ...

Healthcare organisations, including the Kenyan Network of Cancer Organisations (KENCO) and the NCD Alliance Kenya (NCDAK), have condemned the deteriorating health services for cancer patients, calling ...

Breast cancers can be classified into subgroups that hint at the aggressiveness of the cancer and the likelihood that the ...

Shares of solid tumor concern Zymeworks Inc. have barely budged since the company obtained its first approval. Click here to read why ZYME stock is a Hold.

The latest Herceptin biosimilar is branded as Kanjinti (trastuzumab-anns) and is approved in all indications of the reference product. These are for the treatment of HER2-overexpressing adjuvant ...

Ontruzant, the first biosimilar version of Roche’s Herceptin (trastuzumab ... and is indicated for the treatment of early breast cancer, metastatic breast cancer and metastatic gastric cancer.

I tell people I feel blessed to not be diagnosed with cancer in the US. Right now pauses on federal funding, including grants ...

For many women battling breast cancer, or any other type of cancer, the journey is not just about surviving, but also ...

The scarcity has left vulnerable populations at significant risk, with public health experts warning that prolonged stockouts ...

In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46% and ...